{"id":1219,"date":"2021-01-22T00:08:46","date_gmt":"2021-01-22T00:08:46","guid":{"rendered":"https:\/\/vbd.casn.ca\/?page_id=1219"},"modified":"2021-04-28T15:28:38","modified_gmt":"2021-04-28T15:28:38","slug":"module-four-references","status":"publish","type":"page","link":"https:\/\/vbd.casn.ca\/index.php\/module-four-references\/","title":{"rendered":"Module Four References"},"content":{"rendered":"

The content of Module Four was sourced from the following:<\/p>\n

    \n
  • Adrion, E. R., Aucott, J., Lemke, K. W., & Weiner, J. P. (2015).<\/strong> Health care costs, utilization and patterns of care following Lyme disease. PloS One, 10(2), e0116767.\n
  • Ali, A., Vitulano, L., Lee, R., Weiss, T. R., & Colson, E. R. (2014).<\/strong> Experiences of patients identifying with chronic Lyme disease in the healthcare system: A qualitative study. BMC Family Practice, 15(79). https:\/\/doi.org\/10.1186\/1471-2296-15-7\n
  • Allan, B., & Smylie, J. (2015).<\/strong> First Peoples, second class treatment: The role of racism in the health and well-being of Indigenous Peoples in Canada. Wellesley Institute. https:\/\/www.wellesleyinstitute.com\/wp-content\/uploads\/2015\/02\/Summary-First-Peoples-Second-Class-Treatment-Final.pdf\n
  • Association of Medical Microbiology and Infectious Diseases Canada (2019).<\/strong> AMMI Canada position statement on the diagnosis and treatment of people with persistent symptoms that have been attributed to Lyme disease. Retrieved from https:\/\/www.ammi.ca\/Content\/03.17.19%20AMMI%20Canada%20Position%20Statement%20%28EN%29.pdf\n
  • Aucott J. N., Rebman A. W., Crowder L. A., & Kortte K. B. (2013).<\/strong> Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Quality of Life Research, 22, 75-84. Doi: 10.1007\/s11136-012-0126-6\n
  • Beaulieu, L. (2020).<\/strong> D\u00e9voiler l’exp\u00e9rience et la r\u00e9alit\u00e9 contextuelle des personnes atteintes de la maladie de Lyme chronique (MLC) au Canada Atlantique – Ethnographie critique (unpublished Master\u2019s dissertation). Universit\u00e9 de Moncton: Moncton NB.\n
  • Berger, J. J. & Hayes, B. K. (2018).<\/strong> Tick-borne disease working group: 2018 Report to Congress. Department of Health and Human Services. https:\/\/www.hhs.gov\/sites\/default\/files\/tbdwg-report-to-congress-2018.pdf\n
  • Borchers, A. T., Keen, C. L., Huntley, A. C., & Gershwin, M. E. (2015).<\/strong> Lyme disease: A rigorous review of diagnostic criteria and treatment. Journal of Autoimmunity, 57, 82-115. https:\/\/doi.org\/10.1016\/j.jaut.2014.09.004\n
  • Boudreau, C.R., Lloyd, V.K., & Gould, O.N. (2018).<\/strong> Motivations and experiences of Canadians seeking treatment for Lyme disease outside of the conventional Canadian health-care system. Journal of Patient Experience, 5(2), 120-126. doi: https:\/\/doi.org\/10.1177\/2374373517736385\n
  • Bransfield, R.C. (2017).<\/strong> Suicide and Lyme and associated diseases. Neuropsychiatric Disease and Treatment, 13, 1575-1587. doi: 10.2147\/NDT.S136137\n
  • Butler T. (2017).<\/strong> The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: A review of recent cases and our understanding of pathogenesis. The American Journal of Tropical Medicine and Hygiene, 96(1), 46\u201352. https:\/\/doi.org\/10.4269\/ajtmh.16-0434\n
  • Cameron, B. L., Pilar Carmargo Plazas, M., Salas, A. S., Bourque Bearskin, R. L., & Hungler, K. (2014).<\/strong> Understanding inequalities in access to health care services for aboriginal people: A call for nursing action. Advances in Nursing Science, 37(3), E1-E16. doi: 10.1097\/ANS.0000000000000039\n
  • Campbell-Lendrum, D., Manga, L., Bagayoko, M., & Sommerfeld, J. (2015).<\/strong> Climate change and vector-borne diseases: what are the implications for public health research and policy? Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1665), 20130552. https:\/\/doi.org\/10.1098\/rstb.2013.0552\n
  • CanLyme. (n.d). Lyme Diagnosis.<\/strong> Retrieved January 19, 2021 https:\/\/canlyme.com\/just-diagnosed\/\n
  • Cardenas-de la Garza, J. A., De la Cruz-Valadez, E., Ocampo-Candiani, J., & Welsh, O. (2019).<\/strong> Clinical spectrum of Lyme disease. European Journal of Clinical Microbiology & Infectious Diseases, 38(2), 201-208. doi: 10.1007\/s10096-018-3417-1\n
  • Centers for Disease Control and Prevention (2018).<\/strong> West Nile virus: Treatment and prevention. https:\/\/www.cdc.gov\/westnile\/healthcareproviders\/healthCareProviders-TreatmentPrevention.html\n
  • Centers for Disease Control and Prevention (2019).<\/strong> Post-treatment Lyme disease syndrome. https:\/\/www.cdc.gov\/lyme\/postlds\/index.html\n
  • Centers for Disease Control and Prevention (2020a).<\/strong> Lyme disease frequently asked questions (FAQ). https:\/\/www.cdc.gov\/lyme\/faq\/index.html\n
  • Centers for Disease Control and Prevention (2020b).<\/strong> Signs and symptoms of untreated Lyme disease. https:\/\/www.cdc.gov\/lyme\/signs_symptoms\/index.html\n
  • Centres for Disease Control and Prevention. (n.d.).<\/strong> West Nile Virus (WNV) fact sheet. https:\/\/www.cdc.gov\/westnile\/resources\/pdfs\/wnvFactsheet_508.pdf\n
  • Chaaya, G., Jaller-Char, J. J., & Ali, S. K. (2016).<\/strong> Beyond the bull’s eye: Recognizing Lyme disease. Journal of Family Practice, 65(6), 373-380. https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/content_3a7d8058cb82b990e7_JFP_06506_Article2.PDF\n
  • Cook, M. J. (2015).<\/strong> Lyme borreliosis: A review of data on transmission time after tick attachment. International Journal of General Medicine, 8, 1-8. doi: 10.2147\/IJGM.S73791\n
  • Davidsson, M. (2018).<\/strong> The financial implications of a well-hidden and ignored chronic Lyme disease pandemic. Healthcare, 6(16), 1-50. doi:10.3390\/healthcare6010016\n
  • Drew, D. & Hewitt, H. (2006).<\/strong> A qualitative approach to understanding patients\u2019 diagnosis of Lyme disease. Public Health Nursing, 23(1), 20-26. https:\/\/doi.org\/10.1111\/j.0737-1209.2006.230104.x\n
  • Fallon, B. A., Zubcevik, N., Bennett, C., Doshi, S., Rebman, A. W., Kishon, R., Moeller, J. R., Octavien, N. R., & Aucott, J. N. (2019).<\/strong> The General Symptom Questionnaire-30 (GSQ-30): A brief measure of multi-system symptom burden in Lyme disease. Frontiers in Medicine, 6, 283. https:\/\/doi.org\/10.3389\/fmed.2019.00283\n
  • Feng, J., Li, T., Yee, R., Yuan, Y., Bai, C., Cai, M., Shi, W., Embers, M., Brayton, C., Saeki, H., Gabrielson, K., & Zhang, Y. (2019).<\/strong> Stationary phase persister\/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure. Discovery Medicine, 27(148), 125\u2013138.\n
  • Furgal, C. (2010).<\/strong> Health impacts of climate change in Canada\u2019s North. In Seguin, J. (Ed). Human health in a changing climate: A Canadian assessment of vulnerabilities and adaptive capacity (pp. 307-366). Ottawa, ON: Health Canada.\n
  • Goodman, A., Fleming, K., Markwick, N., Morrison, T., Lagimodiere, L., Kerr, T., & Western Aboriginal Harm Reduction Society (2017).<\/strong> \u201cThey treated me like crap and I know it was because I was Native\u201d: The healthcare experiences of Aboriginal peoples living in Vancouver’s inner city. Social Science & Medicine, 178, 87-94. https:\/\/doi.org\/10.1016\/j.socscimed.2017.01.053\n
  • Government of Alberta (2019).<\/strong> Lyme disease. Retrieved from https:\/\/myhealth.alberta.ca\/health\/pages\/conditions.aspx?Hwid=hw77226\n
  • Government of Canada (2015).<\/strong> For health professionals: West Nile virus https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/west-nile-virus\/health-professionals-treating-west-nile-virus.html\n
  • Government of Canada (2016).<\/strong> Treatment of West Nile virus. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/west-nile-virus\/treatment-west-nile-virus.html\n
  • Government of Canada (2017a).<\/strong> What are the symptoms of Lyme disease? https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/symptoms-lyme-disease.html\n
  • Government of Canada (2017b).<\/strong> Treatment of Lyme disease. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/treatment-lyme-disease.html\n
  • Government of Canada (2017c).<\/strong> Lyme disease in Canada: A federal framework. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/lyme-disease-canada-federal-framework.html\n
  • Government of Canada (2018).<\/strong> National case definition: Lyme disease. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/health-professionals-lyme-disease\/national-case-definition.html\n
  • Government of Canada (2019).<\/strong> Lyme disease and pregnancy. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease.html\n
  • Government of Canada (2020a).<\/strong> Travel-related diseases. https:\/\/travel.gc.ca\/travelling\/health-safety\/diseases\n
  • Government of Canada (2020b).<\/strong> For health professionals: Lyme disease. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/lyme-disease\/health-professionals-lyme-disease.html\n
  • Government of Canada. (2020c).<\/strong> Reported cases from 1924 to 2018 in Canada – notifiable diseases on-line. https:\/\/dsol-smed.phac-aspc.gc.ca\/dsol-smed\/ndis\/charts.php?c=pl\n
  • Hatchette, T.F., Davis, I., & Johnston, B.L. (2014).<\/strong> Lyme disease: Clinical diagnosis and treatment. Canadian Communicable Disease Report 40(11), 194-208. https:\/\/doi.org\/10.14745.ccdr.v40i11a01\n
  • Hawkins, R. (2019).<\/strong> Dr. Ralph Hawkins, Canada\u2019s renegade chronic Lyme disease doctor . Canadian Broadcast Corporation https:\/\/www.cbc.ca\/player\/play\/1605847107683\n
  • Horrill, T., McMillan, D. E., Schultz, A. S., & Thompson, G. (2018).<\/strong> Understanding access to healthcare among Indigenous peoples: A comparative analysis of biomedical and postcolonial perspectives. Nursing Inquiry, 25(3), e12237. doi: 10.1111\/nin.12237\n
  • International Lyme and Associated Disease Society (2014).<\/strong> Evidence Based Treatment Guidelines. https:\/\/www.ilads.org\/patient-care\/ilads-treatment-guidelines\/\n
  • International Lyme and Associated Disease Society [ILADS]. (2021).<\/strong> Controversies & challenges in treating Lyme and other tick-borne diseases. https:\/\/www.ilads.org\/research-literature\/controversies-challenges\/\n
  • Johnson, L., Shapiro, M., & Mankoff, J. (2018).<\/strong> Removing the mask of average treatment effects in chronic Lyme disease research using big data and subgroup analysis. Healthcare, 6(124), 1-20. http:\/\/www.mdpi.com\/2227-9032\/6\/4\/124\n
  • Johnson, L., Wilcox S., Mankoff, J., & Stricker R.B. (2014).<\/strong> Severity of chronic Lyme disease compared to other chronic conditions: A quality of life survey. PeerJ, 2, e322. DOI: 10.7717\/peerj.322\n
  • Kule\u0161, J., Potocnakova, L., Bhide, K., Tomassone, L., Fuehrer, H. P., Horvati\u0107, A., Galan, A., Guillemin, N., Nizic, P., Mrljak, V., & Bhide, M. (2017).<\/strong> The challenges and advances in diagnosis of vector-borne diseases: Where do we stand?. Vector-Borne and Zoonotic Diseases, 17(5), 285-296.\n
  • Lapum, J., St-Amant, O., Hughes, M., Petrie, P., Morrell, S., and Mistry, S. (2019).<\/strong> The complete subjective health assessment. Retrieved from https:\/\/ecampusontario.pressbooks.pub\/healthassessment\/\n
  • Lloyd, V. K., & Hawkins, R. G. (2018).<\/strong> Under-detection of Lyme disease in Canada. Healthcare 6(4): doi:10.3390\/healthcare6040125.\n
  • Lyme Disease Task Force. (2018).<\/strong> Report of the Lyme disease and tick-borne illnesses task force. http:\/\/www.health.gov.on.ca\/en\/common\/ministry\/publications\/reports\/lyme_18\/ldtf_final_report_2018.pdf\n
  • MacLeod, M. (2019, January 20).<\/strong> Mothers on a mission to prove Lyme disease can be passed to unborn child. CTV. https:\/\/www.ctvnews.ca\/health\/mothers-on-a-mission-to-prove-lyme-disease-can-be-passed-to-unborn-child-1.4261403\n
  • Marchese, N. M., & Primer, S. R. (2013).<\/strong> Targeting Lyme disease. Nursing 2019, 43(5), 28-33. doi: 10.1097\/01.NURSE.0000428691.49098.16\n
  • Mathieu, K. & Karmali, M. (2016).<\/strong> Vector-borne diseases, climate change and healthy urban living: Next steps. Canadian Communicable Disease Report, 42, 219-21. https:\/\/doi.org\/10.14745\/ccdr.v42i10a13\n
  • Matthews, R. (2017).<\/strong> The cultural erosion of Indigenous people in health care. Canadian Medical Association Journal, 189(2), E78-E79. doi: 10.1503\/cmaj.160167\n
  • McGhee, S., Visovksy, C., Zambroski, C., & Finnegan, A. (2018).<\/strong> Lyme disease: recognition and management for emergency nurses. Emergency Nurse, 26(3). https:\/\/www.researchgate.net\/publication\/326953784_Lyme_disease_Recognition_and_management_for_emergency_nurses\n
  • Moore, K. S. (2015).<\/strong> Lyme disease: Diagnosis, treatment guidelines, and controversy. The Journal for Nurse Practitioners, 11(1), 64-69. doi: https:\/\/doi.org\/10.1016\/j.nurpra.2014.09.021\n
  • Muise, G. M. (2019).<\/strong> Enabling cultural safety in Indigenous primary healthcare. Healthcare management Forum, 32(1), 25-31. Los Angeles, CA: SAGE Publications.\n
  • MyLymeData (2019).<\/strong> 2019 chart book – MyLymeData registry: Project of Lymedisease.org. Retrieved from lymedisease.org\/2019-mylymedata-highlights.pdf\n
  • National Institute for Health and Care Excellence. (2018).<\/strong> Lyme disease: Recommendations. https:\/\/www.nice.org.uk\/guidance\/ng95\n
  • Nolan, L. (2020).<\/strong> How medical education is missing the bull\u2019s-eye. New England Journal of Medicine, 382(26), 2489-2491. doi:10.1056\/NEJMp1915891. www.nejm.org\/doi\/pdf\/10.1056\/NEJMp1915891?listPDF=true\n
  • Nursing Council of New Zealand. (2005).<\/strong> Guidelines for cultural safety, the Treaty of Waitangi and Maori Health in Nursing Education and Practice. Retrieved from www.nursingcouncil.org.nz\n
  • Oppong, J. R. (2020).<\/strong> Globalization of communicable diseases. International Encyclopedia of Human Geography, 6, 223-228. doi: 10.1016\/B978-0-08-102295-5.10438-X\n
  • Palmieri, J. R., Kushwaha-Wagner, A., Bekele, A. M., Chang, J., Nguyen, A. et al. (2019).<\/strong> Missed diagnosis and the development of acute and late Lyme disease in dark skinned populations of Appalachia. Biomedical Journal of Scientific & Technical Research, 21(2), 15782-15787. doi: 10.26717\/BJSTR.2019.21.003583\n
  • Patel, S., Brandon, N., Mabaya, G., & Phillips, L. (2019).<\/strong> Public Health Ontario: Diagnosing and managing early Lyme disease in Ontario. https:\/\/www.hqontario.ca\/Events\/Diagnosing-and-Managing-Early-Lyme-Disease-in-Ontario\n
  • Patton, S. & Phillips, B. (2018).<\/strong> Lyme disease: Diagnosis, treatment and prevention. American Journal of Nursing, 118(4), 38-45. doi: 10.1097\/01.NAJ.0000532071.32468.f7\n
  • Punch, D. (2018).<\/strong> Ticking Lyme bomb. Registered Nurse Journal. Retrieved from https:\/\/rnao.ca\/sites\/rnao-ca\/files\/RNJ-MayJune2018_ticking_lyme_bomb.pdf\n
  • Raffetin, A., Saunier, A., Bouiller, K., Caraux-Paz, P., Eldin, C., Gallien, S., Jouenne, R., Belkacem, A., Salomon, J., Talagrand-Reboul, E. Jaulhac, B., & Grillon, A. (2020).<\/strong> Unconventional diagnostic tests for Lyme borreliosis: A systematic review. Clinical Microbiology and Infection, 26(1), 51-59. doi: https:\/\/doi.org\/10.1016\/j.cmi.2019.06.033\n
  • Rebman, A. W., & Aucott, J. N. (2020).<\/strong> Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Frontiers in Medicine, 7(57). doi: 10.3389\/fmed.2020.00057\n
  • Rebman, A. W., Bechtold, K. T., Yang, T., Mihm, E. A., Soloski, M. J., Novak, C. B., & Aucott, J. N. (2017).<\/strong> The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Frontiers in Medicine, 4, 224. doi: 10.3389\/fmed.2017.00224\n
  • Scott, J. D., Clark, K. L., Foley, J. E., Anderson, J. F., Bierman, B. C., & Durden, L. A. (2018).<\/strong> Extensive distribution of the Lyme disease bacterium, Borrelia burgdorferi Sensu Lato, in multiple tick species parasitizing avian and mammalian hosts across Canada. Healthcare (Basel, Switzerland), 6(4), 131. https:\/\/doi.org\/10.3390\/healthcare6040131\n
  • Shor, W., Green C., Szantyr B., Phillips S., Liegner K., Burrascano J., Bransfield R., & Maloney W.L. (2019).<\/strong> Chronic Lyme disease: An evidence-based definition by the ILADS working group. Antibiotics, 8, 269. doi: 10.3390\/antiobiotics8040269\n
  • Smith, G. N., Moore, K. M., Hatchette, T. F., Nicholson, J., Bowie, W., Langley, J. M. (2020).<\/strong> Committee opinion no.399: Management of tick bites and Lyme disease during pregnancy. Journal of Obstetrics and Gynaecology Canada, 42(5), 644.\n
  • Statistics Canada. (2019).<\/strong> Travel between Canada and other countries, December 2019. https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/200221\/dq200221b-eng.htm\n
  • Truth and Reconciliation Commission of Canada. (2015).<\/strong> Honouring the truth, reconciling for the future: Summary of the final report of the Truth and Reconciliation Commission of Canada. Truth and Reconciliation Commission of Canada. http:\/\/nctr.ca\/assets\/reports\/Final%20Reports\/Executive_Summary_English_Web.pdf\n
  • Waddell, L. A., Greig, J., Lindsay, L. R., Hinckley, A. F., & Ogden, N. H. (2018).<\/strong> A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PloS One, 13(11). doi: https:\/\/doi.org\/10.1371\/journal.pone.0207067\n
  • Ward, C., Branch, C., & Fridkin A. (2016).<\/strong> What is Indigenous cultural safety\u2014and why should I care about it? Visions Journal, 11 (4). Retrieved from https:\/\/www.heretohelp.bc.ca\/visions\/indigenous-people-vol11\/what-indigenous-cultural-safety-and-why-should-i-care-about-it#:~:text=This%20is%20the%20heart%20of,as%20these%20relate%20to%20Indigenous\n
  • World Health Organization [WHO]. (2020).<\/strong> WHOQOL: Measuring quality of life. Retrieved from https:\/\/www.who.int\/toolkits\/whoqol\n
  • World Health Organization. (n.d.).<\/strong> West Nile virus in the WHO European region. Retrieved from https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0020\/246170\/Fact-sheet-West-Nile-virus-Eng.pdf\n
  • Wormser, G., Dattwyler, R., Shapiro, E., Halperin, J., Steere, A., Klempner, M., Krause, P., Bakken, J., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, S., & Nadelman, R. (2006).<\/strong> The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43(9), 1089-1134. https:\/\/doi.org\/10.1086\/508667\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"_links":{"self":[{"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/pages\/1219"}],"collection":[{"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/comments?post=1219"}],"version-history":[{"count":0,"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/pages\/1219\/revisions"}],"wp:attachment":[{"href":"https:\/\/vbd.casn.ca\/index.php\/wp-json\/wp\/v2\/media?parent=1219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}